Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

NCT02620423 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

BIOLOGICAL: REOLYSIN®
DRUG: Chemotherapy
DRUG: Gemcitabine
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5-fluorouracil
DRUG: Pembrolizumab

Sponsor

Oncolytics Biotech